Pituitary adenylate cyclase-activating peptide affects homeostatic sleep regulation in healthy young men

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 3, 2007, Pages

  Murck, Harald ^a,b   Steiger, Axel ^a   Frieboes, Ralf M ^a   Antonijevic, Irina A ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cortisol; Growth hormone; Prolactin

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PLACEBO; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROLACTIN RELEASE; SLEEP; SLEEP DEPRIVATION;

ADULT; ELECTROENCEPHALOGRAPHY; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; MALE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PLACEBOS; SLEEP; SPECTRUM ANALYSIS;

EID: 33947157140     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00152.2006     Document Type: Article

References (30)

1. Ahnaou A, Basille M, Gonzalez B, Vaudry H, Hamon M, Adrien J, Bourgin PP. Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat. Eur J Neurosci 11: 4051-4058, 1999.
2. Arimura A, Shioda S. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 16: 53-88, 1995.
3. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129: 2787-2789, 1991.
4. Banks WA, Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S. Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann NY Acad Sci 805, 270-279, 1996.
5. Bekkers JM, Stevens CF. NMDA receptors at excitatory synapses in the hippocampus: test of a theory of magnesium block. Neurosci Lett 156: 73-77, 1993.
6. Benington JH, Heller HC. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 45: 347-360, 1995.
7. Borbély AA. A two process model of sleep regulation. Hum Neurobiol 1: 195-204, 1982.
8. Chen C, Hardy M, Zhang J, Lahoste GJ, Bazan NG. Altered NMDA receptor trafficking contributes to sleep deprivation-induced hippocampal synaptic and cognitive impairments. Biochem Biophys Res Commun 340: 435-440, 2006.
9. Christophe J. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta 1154: 183-199, 1993.
10. Endo T, Schwierin B, Borbély AA, Tobler I. Selective and total sleep deprivation: effect on the sleep EEG in the rat. Psychiatry Res 66: 97-110, 1997.
11. Fang J, Payne L, Krueger JM. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats. Brain Res 686: 23-28, 1995.
12. Feinberg I, Floyd TC, March JD. Effects of sleep loss on delta (0.3-3 Hz) EEG and eye movement density: new observations and hypotheses. Electroencephalogr Clin Neurophysiol 67: 217-221, 1987.
13. Harmar AJ. An essential role for peptidergic signaling in the control of circadian rhythms in the suprachiasmatic nuclei. J Neuroendocrinol 15: 335-338, 2003.
14. Held K, Antonijevic IA, Künzel H, Uhr M, Wetter TC, Golly IC, Steiger A, Murck H. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 35: 135-143, 2002.
15. Macdonald DS, Weerapura M, Beazely MA, Martin L, Czerwinski W, Roder JC, Orser BA, MacDonald JF. Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src. J Neurosci 25: 11374-11384, 2005.
16. Magistretti PJ, Cardinaux JR, Martin JL. VIP and PACAP in the CNS: regulators of glial energy metabolism and modulators of glutamatergic signaling. Ann NY Acad Sci 865: 213-225, 1998.
17. McDermott CM, Hardy MN, Bazan NG, Magee JC. Sleep-deprivation induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus. J Physiol 570: 553-565, 2006.
18. Murck H, Antonijevic IA, Schier T, Frieboes RM, Barthelmes J, Steiger A. Aging does not affect the sleep endocrine response to total sleep deprivation in humans. Neurobiol Aging 20: 665-668, 1999.
19. Murck H, Guldner J, Colla-Mü ller M, Frieboes RM, Schier T, Wiedemann K, Holsboer F, Steiger A. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. Am J Physiol Regul Integr Comp Physiol 271: R905-R911, 1996.
20. Murck H, Held K, Ziegenbein M, Kü nzel H, Koch K, Steiger A. The renin-angiotensin-aldosterone system in patients with depression compared with controls - a sleep endocrine study. BMC Psychiatry 3: 15, 2003.
21. Murck H, Steiger A. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men - possible therapeutical implications. Psychopharmacology (Berl) 137: 247-252, 1998.
22. Obál F Jr, Sary G, Alföldi P, Rubicsek G, Obál F. Vasoactive intestinal polypeptide promotes sleep without effects on brain temperature in rats at night. Neurosci Lett 64: 236-240, 1986.
23. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: US Department of Health, Education, and Welfare, Neurological Information Network, 1968.
24. Riou F, Cespuglio R, Jouvet M. Hypnogenic properties of the vasoactive intestinal polypeptide in rats. C R Seances Acad Sci III 293: 679-682, 1981.
25. Roberto M, Brunelli M. PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CA1 region. Learn Mem 7: 303-311, 2000.
26. Simon-Arceo K, Ramirez-Salado I, Calvo JM. Long-lasting enhancement of rapid eye movement sleep and pontogeniculooccipital waves by vasoactive intestinal peptide microinjection into the amygdala temporal lobe. Sleep 26: 259-264, 2003.
27. Simonneaux V, Kienlen-Campard P, Loeffler JP, Basille M, Gonzalez BJ, Vaudry H, Robberecht P, Pevet P. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland. Neuroscience 85: 887-896, 1998.
28. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175, 1993.
29. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52: 269-324, 2000.
30. Werth E, Dijk DJ, Achermann P, Borbély AA. Dynamics of the sleep EEG after an early evening nap: experimental data and simulations. Am J Physiol Regul Integr Comp Physiol 271: R501-R510, 1996.